SCHEMBL24319703

SCHEMBL24319703

CCC(C)(C)NS(=O)(=O)c1cccc(Br)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 1/20 0.43
TP53 P04637 1/20 0.37
ALOX5AP P20292 2/20 0.34
FEN1 P39748 2/20 0.34
ALDH1A1 P00352 3/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TSHR P16473 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ATM Q13315 1/20 0.31
GAA P10253 1/20 0.31
KDM4E B2RXH2 2/20 0.31
EDNRA P25101 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2996719 0.84 MAPT (0.45) PARGALOX5APFEN1ALDH1A1SMN1; SMN2
SCHEMBL3560744 0.71 RECQL (0.53) PARGTP53ALOX5APFEN1TDP1
SCHEMBL245099 0.70 DHFR (0.41) ALDH1A1SMN1; SMN2TDP1TSHRKDM4E
SCHEMBL29703778 0.70 CA12 (0.43) SMN1; SMN2GAAMEN1NPC1RAB9A
SCHEMBL30253017 0.69 LOX (0.41) ALDH1A1SMN1; SMN2EDNRALMNAHPGD
SCHEMBL1404067 0.69 LOX (0.41) ALDH1A1SMN1; SMN2EDNRALMNAHPGD
SCHEMBL12753812 0.69 HTR7 (0.33) ALDH1A1IRAK4SMN1; SMN2CCR4
SCHEMBL5812323 0.68 PARG (0.62) PARGALDH1A1SMN1; SMN2TDP1L3MBTL1
SCHEMBL19786784 0.66 CDK1 (0.33)
SCHEMBL29703690 0.66 GAA (0.44) ALDH1A1SMN1; SMN2L3MBTL1GAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220073504-A1 KIF18A INHIBITORS AMGEN INC. (US) 2022-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073504-A1 KIF18A INHIBITORS KIF18A, KIF18B, KIF15 PARG 3984/4885TP53 204/4885ALOX5AP 4708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.